Clinical Trial Update: Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux

View source ↗

Summary

The trial evaluating outpatient management of stable acute pulmonary embolism using fondaparinux (Arixtra) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• ARIXTRA (fondaparinux sodium)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Pulmonary Embolism | Status: WITHDRAWN